Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Amino-acid PET Versus MRI Guided Re-irradiation in Patients With Recurrent Glioblastoma Multiforme - a Randomised Phase II Trial

NCT01252459 is registered in ClinicalTrials.gov with University Hospital Freiburg as lead sponsor.

NCT NCT01252459
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01252459 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Amino-acid PET Versus MRI Guided Re-irradiation in Patients With Recurrent Glioblastoma Multiforme - a Randomised Phase II Trial
Lead sponsor
University Hospital Freiburg
Phase
Phase 2
Overall status
Unknown status
Start date
July 31, 2011
Completion date
July 31, 2014
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent glioma (glioblastoma multiforme)